Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3be34e7affec9441bd2d971e292b2a81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c59eccbb6de22c1d3c8b68f789e58e4d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b40815cd66866ad49aa10803ba5dbc32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_87dc9793ccbbef047939564ee7e10c2e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0607c02c591c0881c2f44175cb4a1a8e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D451-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
filingDate |
2006-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb7e398b7f616f70b51a737b232b0985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_830994e26b7cfc2140b6bbda7418bbdc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c929da31ac08d5ad2dc61e56269b3b4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27e03eb8b427575370c89a39191d267e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4947ffeb83c7dc84b5f631a8298b502 |
publicationDate |
2007-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2007063000-A1 |
titleOfInvention |
5-substituted indole-2-carboxamide derivatives |
abstract |
The present invention relates to compounds of formula (I) wherein R1 to R4 and G are as defined in the description and claims and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011070253-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7507736-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008095821-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2953521-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2010329762-B2 |
priorityDate |
2005-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |